Through ultra-sensitive InSituPlex® assays and advanced, AI-driven spatial analysis, Ultivue empowers scientists developing precision cancer therapies to generate quantitative, high-confidence insights in just a fraction of the time. Ultivue’s Spatial Image Analysis pipeline utilizes AI and advanced analytics to unlock precise, quantitative insights into the spatial biology of the tumor microenvironment. Its cross-functional team, consisting of Pathology, AI Engineering, and Data Science experts, employs advanced Deep Learning approaches and a proprietary image analysis platform, UltiAnalyzer.AI™, to analyze multiplex immunofluorescence images at scale. The integration of OMERO Plus for slide organization and PathViewer for visualization and annotations enables engineers at Ultivue to develop various types of AI models, from cell detection to region segmentation, in a cloud environment. Ultivue’s end-to-end portfolio of solutions simplifies the biomarker journey from biological samples to high-confidence quantitative insights, empowering its partners to make critical, data-driven research decisions more swiftly and cost-effectively.














